{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T13:13:10Z","timestamp":1775049190133,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.7759\/cureus.106267","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:52:55Z","timestamp":1775044375000},"source":"Crossref","is-referenced-by-count":0,"title":["Refractory Autoimmune Hemophagocytic Lymphohistiocytosis in Adults: Multi-therapy Failure and the Limits of Salvage Transplantation"],"prefix":"10.7759","author":[{"given":"Bsher","family":"Almaalouli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel R","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Courant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurjit S","family":"Kaeley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals M","year":"2014","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, L\u00f3pez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014, 383:1503-16. 10.1016\/S0140-6736(13)61048-X","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.11.050","article-title":"Hemophagocytic lymphohistiocytosis: clinical presentations and diagnosis","volume":"7","author":"Risma KA","year":"2019","unstructured":"Risma KA, Marsh RA. Hemophagocytic lymphohistiocytosis: clinical presentations and diagnosis. J Allergy Clin Immunol Pract. 2019, 7:824-32. 10.1016\/j.jaip.2018.11.050","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-551622","article-title":"How I treat hemophagocytic lymphohistiocytosis in the adult patient","volume":"125","author":"Schram AM","year":"2015","unstructured":"Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015, 125:2908-14. 10.1182\/blood-2015-01-551622","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000022","article-title":"Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients","volume":"93","author":"Li J","year":"2014","unstructured":"Li J, Wang Q, Zheng W, Ma J, Zhang W, Wang W, Tian X. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore). 2014, 93:100-5. 10.1097\/MD.0000000000000022","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.12.012","article-title":"Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis","volume":"89","author":"Parikh SA","year":"2014","unstructured":"Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014, 89:484-92. 10.1016\/j.mayocp.2013.12.012","journal-title":"Mayo Clin Proc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000936","article-title":"Pediatric hemophagocytic lymphohistiocytosis","volume":"135","author":"Canna SW","year":"2020","unstructured":"Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020, 135:1332-43. 10.1182\/blood.2019000936","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-016-0216-x","article-title":"Hemophagocytic lymphohistiocytosis : a diagnostic challenge on the ICU. (Article in German)","volume":"65","author":"Lachmann G","year":"2016","unstructured":"Lachmann G, La Ros\u00e9e P, Schenk T, Brunkhorst FM, Spies C. Hemophagocytic lymphohistiocytosis : a diagnostic challenge on the ICU. (Article in German). Anaesthesist. 2016, 65:776-86. 10.1007\/s00101-016-0216-x","journal-title":"Anaesthesist"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcx183","article-title":"Clinical features and outcomes in secondary adult hemophagocytic lymphohistiocytosis","volume":"111","author":"Zhou M","year":"2018","unstructured":"Zhou M, Li L, Zhang Q, et al.. Clinical features and outcomes in secondary adult hemophagocytic lymphohistiocytosis. QJM. 2018, 111:23-31. 10.1093\/qjmed\/hcx183","journal-title":"QJM"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5492\/wjccm.v7.i6.73","article-title":"Intensive care unit complications and outcomes of adult patients with hemophagocytic lymphohistiocytosis: a retrospective study of 16 cases","volume":"7","author":"Kapoor S","year":"2018","unstructured":"Kapoor S, Morgan CK, Siddique MA, Guntupalli KK. Intensive care unit complications and outcomes of adult patients with hemophagocytic lymphohistiocytosis: a retrospective study of 16 cases. World J Crit Care Med. 2018, 7:73-83. 10.5492\/wjccm.v7.i6.73","journal-title":"World J Crit Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006935","article-title":"Clinical features and prognostic factors of adult secondary hemophagocytic syndrome: analysis of 47 cases","volume":"96","author":"Guo Y","year":"2017","unstructured":"Guo Y, Bai Y, Gu L. Clinical features and prognostic factors of adult secondary hemophagocytic syndrome: analysis of 47 cases. Medicine (Baltimore). 2017, 96:e6935. 10.1097\/MD.0000000000006935","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23911","article-title":"Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis","volume":"90","author":"Otrock ZK","year":"2015","unstructured":"Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol. 2015, 90:220-4. 10.1002\/ajh.23911","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/art.41103","article-title":"Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis","volume":"72","author":"Eloseily EM","year":"2020","unstructured":"Eloseily EM, Weiser P, Crayne CB, et al.. Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2020, 72:326-34. 10.1002\/art.41103","journal-title":"Arthritis Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-eular.5193","article-title":"Pos0339 Points to consider at the earliest stages of the diagnosis and management of hemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS)","volume":"81","author":"Shakoory B","year":"2022","unstructured":"Shakoory B, Geerlinks A, Wilejto M, et al.. Pos0339 Points to consider at the earliest stages of the diagnosis and management of hemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS). Ann Rheum Dis. 2022, 81:422. 10.1136\/annrheumdis-2022-eular.5193","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28581","article-title":"The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis","volume":"67","author":"Bami S","year":"2020","unstructured":"Bami S, Vagrecha A, Soberman D, et al.. The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2020, 67:e28581. 10.1002\/pbc.28581","journal-title":"Pediatr Blood Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30156-5","article-title":"Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial","volume":"6","author":"Ahmed A","year":"2019","unstructured":"Ahmed A, Merrill SA, Alsawah F, et al.. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. Lancet Haematol. 2019, 6:e630-7. 10.1016\/S2352-3026(19)30156-5","journal-title":"Lancet Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-644914","article-title":"Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis","volume":"126","author":"Wang Y","year":"2015","unstructured":"Wang Y, Huang W, Hu L, et al.. Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood. 2015, 126:2186-92. 10.1182\/blood-2015-05-644914","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-370148","article-title":"Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH","volume":"118","author":"Zhang K","year":"2011","unstructured":"Zhang K, Jordan MB, Marsh RA, et al.. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011, 118:5794-8. 10.1182\/blood-2011-07-370148","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1599873","article-title":"DEP regimen for the treatment of hemophagocytic lymphohistiocytosis: a review of published experience","volume":"16","author":"Meng G","year":"2025","unstructured":"Meng G, Feng S, Wang Y. DEP regimen for the treatment of hemophagocytic lymphohistiocytosis: a review of published experience. Front Pharmacol. 2025, 16:1599873. 10.3389\/fphar.2025.1599873","journal-title":"Front Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24123","article-title":"Clinical significance of pulmonary nodules detected by CT and not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group","volume":"59","author":"Grundy PE","year":"2012","unstructured":"Grundy PE, Green DM, Dirks AC, Berendt AE, Breslow NE, Anderson JR, Dome JS. Clinical significance of pulmonary nodules detected by CT and not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2012, 59:631-5. 10.1002\/pbc.24123","journal-title":"Pediatr Blood Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12138","article-title":"Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis","volume":"160","author":"Lehmberg K","year":"2013","unstructured":"Lehmberg K, Ehl S. Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. Br J Haematol. 2013, 160:275-87. 10.1111\/bjh.12138","journal-title":"Br J Haematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten E","year":"2017","unstructured":"Bergsten E, Horne A, Aric\u00f3 M, et al.. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017, 130:2728-38. 10.1182\/blood-2017-06-788349","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007012","article-title":"Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis","volume":"7","author":"Gooptu M","year":"2023","unstructured":"Gooptu M, Kim HT, Jacobsen E, et al.. Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis. Blood Adv. 2023, 7:2309-16. 10.1182\/bloodadvances.2022007012","journal-title":"Blood Adv"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01634-5","article-title":"Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT","volume":"57","author":"Machowicz R","year":"2022","unstructured":"Machowicz R, Suarez F, Wiktor-Jedrzejczak W, et al.. Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT. Bone Marrow Transplant. 2022, 57:817-23. 10.1038\/s41409-022-01634-5","journal-title":"Bone Marrow Transplant"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.01.071","article-title":"A nationwide retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult hemophagocytic lymphohistiocytosis","volume":"30","author":"Kim H","year":"2024","unstructured":"Kim H, Mizuno K, Masuda K, et al.. A nationwide retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult hemophagocytic lymphohistiocytosis. Transplant Cell Ther. 2024, 30:419.e1-12. 10.1016\/j.jtct.2024.01.071","journal-title":"Transplant Cell Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.198655","article-title":"Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy","volume":"104","author":"Yoon JH","year":"2019","unstructured":"Yoon JH, Park SS, Jeon YW, et al.. Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy. Haematologica. 2019, 104:269-76. 10.3324\/haematol.2018.198655","journal-title":"Haematologica"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01668-9","article-title":"Efficacy and safety of allogeneic hematopoietic stem cell transplant in adults with hemophagocytic lymphohistiocytosis: a systematic review of literature","volume":"57","author":"Masood A","year":"2022","unstructured":"Masood A, Wahab A, Iqbal Q, Davis J, Ehsan H, Hashmi H. Efficacy and safety of allogeneic hematopoietic stem cell transplant in adults with hemophagocytic lymphohistiocytosis: a systematic review of literature. Bone Marrow Transplant. 2022, 57:866-73. 10.1038\/s41409-022-01668-9","journal-title":"Bone Marrow Transplant"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286477","article-title":"Histiocyte Society blueprint for hemophagocytic lymphohistiocytosis research: deciphering underlying disease mechanisms to optimize diagnosis and therapy","volume":"110","author":"Meyer LK","year":"2025","unstructured":"Meyer LK, Lee JC, Rocco JM, Nichols KE. Histiocyte Society blueprint for hemophagocytic lymphohistiocytosis research: deciphering underlying disease mechanisms to optimize diagnosis and therapy. Haematologica. 2025, 110:2572-87. 10.3324\/haematol.2024.286477","journal-title":"Haematologica"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e P","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M, et al.. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019, 133:2465-77. 10.1182\/blood.2018894618","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin G","year":"2020","unstructured":"Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020, 34:101515. 10.1016\/j.berh.2020.101515","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan MB","year":"2011","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011, 118:4041-52. 10.1182\/blood-2011-03-278127","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/467321-refractory-autoimmune-hemophagocytic-lymphohistiocytosis-in-adults-multi-therapy-failure-and-the-limits-of-salvage-transplantation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:52:58Z","timestamp":1775044378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/467321-refractory-autoimmune-hemophagocytic-lymphohistiocytosis-in-adults-multi-therapy-failure-and-the-limits-of-salvage-transplantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.106267","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}